Chris Ground

Chief Commercial Officer

Chris Ground, FFF Enterprises’ Chief Commercial Officer, began his career in the medical industry in 1982 as a sales representative for Bristol Laboratories. In 1986, Chris joined Cutter Biological as a Sales Representative, and continued with the company when it became Bayer Biologicals. Chris helped launch Bayer’s Gamimune N, intravenous immune globulin; Prolastin, alpha protease inhibitor; and Kogenate, recombinant DNA Factor VIII concentrate. In the course of his 12 years with Bayer Biologicals, Chris held several positions, including Field Sales Representative, Field Sales Trainer, Training Manager and Biological Division Business Manager.

Chris joined FFF Enterprises in 1998 as Vice President of Sales and Marketing, and served as Senior Vice President of National Accounts from 2002 through 2010, during which time he managed FFF Enterprises’ major corporate business partnerships, including group purchasing organizations and manufacturers, as well as guiding FFF’s internal sales operations. During the first decade of this twenty-first century, Chris helped expand FFF’s distribution of biopharmaceuticals from $178 million in annual revenue to more than one billion dollars, making FFF the leading distributor of Albumin, IVIG and Flu Vaccine in the country.

In his current role as Chief Commercial Officer, Chris oversees the various business units and innovative programs for the company. Chris has a passion for patient safety that has helped define the character of FFF and its unyielding commitment to channel integrity.

Chris received a Bachelor of Science Degree in Business Administration in 1980 with an emphasis in Marketing. In 1998, Chris received an MBA from the Peter Drucker Graduate School of Business at Claremont Graduate University.